Webinar: Cannabis horizons: Charting the path forward

The Details

The DEA’s potential rescheduling of cannabis from Schedule I to Schedule III serves as a linchpin in the industry’s optimistic trajectory. Rescheduling would have a domino effect on the industry and how it operates.

Don't miss this opportunity to gain a deeper understanding of where the cannabis industry is headed – and how you can navigate the evolving landscape. Our panel of cannabis industry professionals will share their unique insights and predictions for what they believe lies ahead over the next six months, two years, and five years. The discussion will focus on the current landscape related to DEA rescheduling and the impact it will have on M&A activity and related business valuations.

Recorded on April 23, 2024.

Speakers

Tara Marino
Principal, Valuation Advisory
CohnReznick

(Moderator)

Lane Bruns
CEO
iCanivest

Tracy Gallegos
Partner
Duane Morris

Robert G. Shuler
Managing Partner
Dye Capital

Speakers

3-Col Headline